SOPHiA GENETICS
SOPH | NASDAQ
$7.44
-$0.77 (-9.38%)
At close: Nov 16, 2026, 4:00 PM ET
$7.44
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-9.38%
(1D)No price chart data available for 1D timeframe.
Rating
46.8
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #351/1021 (Top 34%)
Key Statistics
Market Data
Market Cap $633.35M
1D Range
7.42 8.13
52W Range
3.89 8.92
Valuation (TTM)
PE -6.83
PB 9.26
EV/EBITDA -9.07
Valuation (NTM)
Forward PE N/A
Forward PEG 0.51
Price Target $11.50
Cash Flow
FCF Yield -7.7%
SBC Adj. FCF Yield -9.1%
SBC Impact -18.6%
Margins
Gross Margin 66.4%
Operating Margin -80.5%
FCF Margin -53.3%
Growth (CAGR)
Revenue 3Y | 5Y 15.7% |
19.5%
Dil EPS 3Y | 5Y 0.0% |
6.7%
FCF 3Y | 5Y 3.6% |
14.8%
Returns
ROA -43.9%
ROE -132.8%
ROIC -55.3%
Financial Health
Net Cash
$45.51M
Current Ratio 2.29
Interest Coverage -11.13
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineer...
Sector Healthcare
Employees 415
IPO Date Jul 23, 2021
Website www.sophiagenetics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 3, 2026
EPS
-$0.24
Miss -21.21%
YoY:
+20.00% REV
$24.27M
Beat +0.98%
YoY:
+24.69%Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$11.50
Upside
+54.57%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SOPH